Log In
BCIQ
Print this Print this
 

MenACWY-TT, Nimenrix (GSK134612)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionConjugated vaccine against Neisseria meningitidis A, C, W and Y
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentApproved
Standard IndicationMeningitis
Indication DetailsPrevent Neisseria meningitis groups A, C, W and Y disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$130.2M

$130.2M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/22/2015

$130.2M

$130.2M

0

Get a free BioCentury trial today